Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer.
about
Update: the status of clinical trials with kinase inhibitors in thyroid cancerA new aurora in anaplastic thyroid cancer therapy.The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer.Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers.Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death.
P2860
Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Combined inhibition of cellula ...... tal anaplastic thyroid cancer.
@en
Combined inhibition of cellula ...... tal anaplastic thyroid cancer.
@nl
type
label
Combined inhibition of cellula ...... tal anaplastic thyroid cancer.
@en
Combined inhibition of cellula ...... tal anaplastic thyroid cancer.
@nl
prefLabel
Combined inhibition of cellula ...... tal anaplastic thyroid cancer.
@en
Combined inhibition of cellula ...... tal anaplastic thyroid cancer.
@nl
P2093
P2860
P1433
P1476
Combined inhibition of cellula ...... tal anaplastic thyroid cancer.
@en
P2093
Annette Ramaswamy
Annette Wunderlich
Brandon H Greene
Cornelia Brendel
Detlef K Bartsch
Sebastian Hoffmann
Silvia Roth
Ulrike Hinterseher
P2860
P2888
P304
P356
10.1007/S12020-012-9665-4
P577
2012-04-05T00:00:00Z